Eastman Chemical Co has a consensus price target of $102.64 based on the ratings of 28 analysts. The high is $130 issued by Barclays on January 31, 2022. The low is $78 issued by Fermium Research on October 30, 2023. The 3 most-recent analyst ratings were released by Citigroup, UBS, and Barclays on June 27, 2024, May 23, 2024, and May 6, 2024, respectively. With an average price target of $114 between Citigroup, UBS, and Barclays, there's an implied 17.15% upside for Eastman Chemical Co from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/27/2024 | Buy Now | 14.07% | Citigroup | Patrick Cunningham | $114 → $111 | Maintains | Buy | Get Alert |
05/23/2024 | Buy Now | 31.54% | UBS | Joshua Spector | $106 → $128 | Upgrade | Neutral → Buy | Get Alert |
05/06/2024 | Buy Now | 5.85% | Barclays | Michael Leithead | $85 → $103 | Maintains | Equal-Weight | Get Alert |
04/30/2024 | Buy Now | 6.87% | RBC Capital | Arun Viswanathan | $100 → $104 | Maintains | Sector Perform | Get Alert |
04/30/2024 | Buy Now | 7.9% | Piper Sandler | Charles Neivert | $90 → $105 | Maintains | Neutral | Get Alert |
04/29/2024 | Buy Now | 28.46% | Jefferies | Laurence Alexander | $102 → $125 | Upgrade | Hold → Buy | Get Alert |
04/29/2024 | Buy Now | 15.1% | B of A Securities | Steve Byrne | $113 → $112 | Maintains | Buy | Get Alert |
04/26/2024 | Buy Now | 4.82% | Mizuho | John Roberts | $91 → $102 | Maintains | Neutral | Get Alert |
04/19/2024 | Buy Now | 2.76% | RBC Capital | Arun Viswanathan | $89 → $100 | Maintains | Sector Perform | Get Alert |
04/11/2024 | Buy Now | 2.76% | Wells Fargo | Michael Sison | $89 → $100 | Maintains | Equal-Weight | Get Alert |
04/10/2024 | Buy Now | 17.15% | Citigroup | Patrick Cunningham | $95 → $114 | Maintains | Buy | Get Alert |
04/09/2024 | Buy Now | 24.34% | Keybanc | Aleksey Yefremov | $101 → $121 | Maintains | Overweight | Get Alert |
02/15/2024 | Buy Now | 13.04% | Redburn Atlantic | Colin Isaac | → $110 | Initiates | → Buy | Get Alert |
02/06/2024 | Buy Now | -2.37% | Citigroup | Patrick Cunningham | $96 → $95 | Maintains | Buy | Get Alert |
02/06/2024 | Buy Now | -8.54% | RBC Capital | Arun Viswanathan | $91 → $89 | Maintains | Sector Perform | Get Alert |
02/05/2024 | Buy Now | 3.79% | Stifel | Vincent Anderson | $102 → $101 | Maintains | Buy | Get Alert |
02/02/2024 | Buy Now | -4.43% | UBS | Joshua Spector | $91 → $93 | Maintains | Neutral | Get Alert |
01/11/2024 | Buy Now | -6.48% | UBS | Joshua Spector | $89 → $91 | Maintains | Neutral | Get Alert |
01/09/2024 | Buy Now | 3.79% | Keybanc | Aleksey Yefremov | $95 → $101 | Maintains | Overweight | Get Alert |
12/14/2023 | Buy Now | -8.54% | UBS | Joshua Spector | $81 → $89 | Maintains | Neutral | Get Alert |
12/14/2023 | Buy Now | -5.46% | Goldman Sachs | Duffy Fischer | $82 → $92 | Maintains | Neutral | Get Alert |
10/30/2023 | Buy Now | -19.84% | Fermium Research | Frank Mitsch | $82 → $78 | Maintains | Hold | Get Alert |
10/30/2023 | Buy Now | -7.51% | JP Morgan | Jeffrey Zekaukas | → $90 | Upgrade | Neutral → Overweight | Get Alert |
10/30/2023 | Buy Now | -2.37% | Keybanc | Aleksey Yefremov | $98 → $95 | Maintains | Overweight | Get Alert |
10/11/2023 | Buy Now | -17.79% | Piper Sandler | James Fish | $96 → $80 | Maintains | Neutral | Get Alert |
10/11/2023 | Buy Now | -12.65% | Barclays | Michael Leithead | $90 → $85 | Maintains | Equal-Weight | Get Alert |
10/04/2023 | Buy Now | -11.62% | Citigroup | Patrick Cunningham | $99 → $86 | Maintains | Buy | Get Alert |
10/03/2023 | Buy Now | 0.71% | Keybanc | Aleksey Yefremov | $103 → $98 | Maintains | Overweight | Get Alert |
09/29/2023 | Buy Now | -12.65% | Wells Fargo | Michael Sison | $89 → $85 | Maintains | Equal-Weight | Get Alert |
08/03/2023 | Buy Now | -19.84% | Mizuho | Kieran De Brun | $84 → $78 | Maintains | Neutral | Get Alert |
08/01/2023 | Buy Now | 18.18% | Morgan Stanley | Vincent Andrews | $115 → $115 | Reiterates | Overweight → Overweight | Get Alert |
08/01/2023 | Buy Now | -9.57% | RBC Capital | Arun Viswanathan | $83 → $88 | Maintains | Sector Perform | Get Alert |
08/01/2023 | Buy Now | -1.35% | Piper Sandler | Charles Neivert | → $96 | Downgrade | Overweight → Neutral | Get Alert |
07/31/2023 | Buy Now | 1.74% | Citigroup | Patrick Cunningham | $96 → $99 | Maintains | Buy | Get Alert |
07/31/2023 | Buy Now | 18.18% | Morgan Stanley | Vincent Andrews | $115 → $115 | Reiterates | Overweight → Overweight | Get Alert |
07/28/2023 | Buy Now | 0.71% | Credit Suisse | John Roberts | $95 → $98 | Maintains | Outperform | Get Alert |
07/12/2023 | Buy Now | -1.35% | Citigroup | Patrick Cunningham | $91 → $96 | Maintains | Buy | Get Alert |
07/11/2023 | Buy Now | 5.85% | Keybanc | Aleksey Yefremov | $106 → $103 | Maintains | Overweight | Get Alert |
07/06/2023 | Buy Now | -1.35% | Piper Sandler | Charles Neivert | $99 → $96 | Maintains | Overweight | Get Alert |
06/21/2023 | Buy Now | 18.18% | Morgan Stanley | Vincent Andrews | → $115 | Reiterates | Overweight → Overweight | Get Alert |
06/14/2023 | Buy Now | -6.48% | Citigroup | Patrick Cunningham | → $91 | Initiates | → Buy | Get Alert |
06/12/2023 | Buy Now | -11.62% | Deutsche Bank | David Begleiter | $92 → $86 | Maintains | Hold | Get Alert |
05/02/2023 | Buy Now | -13.68% | Mizuho | Kieran De Brun | $82 → $84 | Maintains | Neutral | Get Alert |
05/01/2023 | Buy Now | -7.51% | Barclays | Michael Leithead | $87 → $90 | Maintains | Equal-Weight | Get Alert |
05/01/2023 | Buy Now | 8.93% | Keybanc | Aleksey Yefremov | $96 → $106 | Maintains | Overweight | Get Alert |
04/17/2023 | Buy Now | -8.54% | Wells Fargo | Michael Sison | $95 → $89 | Maintains | Equal-Weight | Get Alert |
04/12/2023 | Buy Now | 1.74% | Piper Sandler | Charles Neivert | $96 → $99 | Upgrade | Neutral → Overweight | Get Alert |
04/11/2023 | Buy Now | -1.35% | Keybanc | Aleksey Yefremov | $98 → $96 | Maintains | Overweight | Get Alert |
01/30/2023 | Buy Now | -5.46% | Vertical Research | Kevin McCarthy | $94 → $92 | Downgrade | Buy → Hold | Get Alert |
01/30/2023 | Buy Now | -15.73% | Mizuho | Kieran De Brun | $85 → $82 | Maintains | Neutral | Get Alert |
01/30/2023 | Buy Now | -10.6% | Barclays | Michael Leithead | $82 → $87 | Maintains | Equal-Weight | Get Alert |
01/30/2023 | Buy Now | -2.37% | Wells Fargo | Michael Sison | $80 → $95 | Maintains | Equal-Weight | Get Alert |
01/30/2023 | Buy Now | -7.51% | Scotiabank | Ben Isaacson | $100 → $90 | Downgrade | Sector Outperform → Sector Perform | Get Alert |
01/27/2023 | Buy Now | 2.76% | Credit Suisse | John Roberts | $95 → $100 | Maintains | Outperform | Get Alert |
01/17/2023 | Buy Now | -1.35% | Deutsche Bank | David Begleiter | $90 → $96 | Downgrade | Buy → Hold | Get Alert |
01/12/2023 | Buy Now | -12.65% | Mizuho | Christopher Parkinson | $88 → $85 | Maintains | Neutral | Get Alert |
01/11/2023 | Buy Now | 10.99% | B of A Securities | Steve Byrne | $98 → $108 | Upgrade | Neutral → Buy | Get Alert |
12/15/2022 | Buy Now | -8.54% | Goldman Sachs | Duffy Fischer | $78 → $89 | Maintains | Neutral | Get Alert |
12/15/2022 | Buy Now | -7.51% | Citigroup | PJ Juvekar | $75 → $90 | Maintains | Neutral | Get Alert |
10/31/2022 | Buy Now | -22.93% | Citigroup | PJ Juvekar | $80 → $75 | Maintains | Neutral | Get Alert |
10/31/2022 | Buy Now | -9.57% | Mizuho | Kieran De Brun | $91 → $88 | Maintains | Neutral | Get Alert |
10/31/2022 | Buy Now | 0.71% | Keybanc | Aleksey Yefremov | $111 → $98 | Maintains | Overweight | Get Alert |
10/28/2022 | Buy Now | -2.37% | Credit Suisse | John Roberts | $102 → $95 | Maintains | Outperform | Get Alert |
10/18/2022 | Buy Now | -17.79% | Wells Fargo | Michael Sison | $95 → $80 | Maintains | Equal-Weight | Get Alert |
10/13/2022 | Buy Now | -19.84% | Goldman Sachs | Duffy Fischer | → $78 | Initiates | → Neutral | Get Alert |
10/12/2022 | Buy Now | 18.18% | Morgan Stanley | Vincent Andrews | $165 → $115 | Maintains | Overweight | Get Alert |
10/11/2022 | Buy Now | -6.48% | Mizuho | Kieran De Brun | → $91 | Initiates | → Neutral | Get Alert |
10/10/2022 | Buy Now | -7.51% | Piper Sandler | Charles Neivert | $103 → $90 | Maintains | Neutral | Get Alert |
09/19/2022 | Buy Now | 10.99% | UBS | Joshua Spector | $118 → $108 | Maintains | Buy | Get Alert |
09/15/2022 | Buy Now | -2.37% | Deutsche Bank | David Begleiter | $115 → $95 | Maintains | Buy | Get Alert |
09/15/2022 | Buy Now | -15.73% | RBC Capital | Arun Viswanathan | $97 → $82 | Maintains | Sector Perform | Get Alert |
09/14/2022 | Buy Now | -4.43% | Citigroup | PJ Juvekar | $102 → $93 | Maintains | Neutral | Get Alert |
09/14/2022 | Buy Now | 14.07% | Keybanc | Aleksey Yefremov | $125 → $111 | Maintains | Overweight | Get Alert |
09/14/2022 | Buy Now | -2.37% | Wells Fargo | Michael Sison | $110 → $95 | Downgrade | Overweight → Equal-Weight | Get Alert |
08/02/2022 | Buy Now | 13.04% | Wells Fargo | Michael Sison | $115 → $110 | Maintains | Overweight | Get Alert |
08/02/2022 | Buy Now | 13.04% | Barclays | Michael Leithead | $120 → $110 | Maintains | Equal-Weight | Get Alert |
08/02/2022 | Buy Now | -0.32% | RBC Capital | Arun Viswanathan | $94 → $97 | Maintains | Sector Perform | Get Alert |
08/01/2022 | Buy Now | — | Citigroup | PJ Juvekar | — | Downgrade | Buy → Neutral | Get Alert |
08/01/2022 | Buy Now | 28.46% | Keybanc | Aleksey Yefremov | $124 → $125 | Maintains | Overweight | Get Alert |
07/29/2022 | Buy Now | 21.26% | UBS | Joshua Spector | $121 → $118 | Maintains | Buy | Get Alert |
07/20/2022 | Buy Now | 27.43% | Keybanc | Aleksey Yefremov | $142 → $124 | Maintains | Overweight | Get Alert |
07/13/2022 | Buy Now | 18.18% | B of A Securities | Matthew DeYoe | $123 → $115 | Maintains | Neutral | Get Alert |
06/23/2022 | Buy Now | 18.18% | Wells Fargo | Michael Sison | $125 → $115 | Maintains | Overweight | Get Alert |
06/16/2022 | Buy Now | -10.6% | Jefferies | Laurence Alexander | $150 → $87 | Downgrade | Buy → Hold | Get Alert |
05/31/2022 | Buy Now | 33.59% | Credit Suisse | John Roberts | → $130 | Initiates | → Outperform | Get Alert |
05/02/2022 | Buy Now | 28.46% | Wells Fargo | Michael Sison | $128 → $125 | Maintains | Overweight | Get Alert |
05/02/2022 | Buy Now | 23.32% | Barclays | Michael Leithead | $130 → $120 | Maintains | Equal-Weight | Get Alert |
04/19/2022 | Buy Now | 17.15% | Wolfe Research | Josh Silverstein | $130 → $114 | Downgrade | Outperform → Peer Perform | Get Alert |
04/19/2022 | Buy Now | 27.43% | B of A Securities | Matthew DeYoe | $150 → $124 | Downgrade | Buy → Neutral | Get Alert |
04/06/2022 | Buy Now | 31.54% | Wells Fargo | Michael Sison | $138 → $128 | Maintains | Overweight | Get Alert |
04/05/2022 | Buy Now | 45.93% | Keybanc | Aleksey Yefremov | $150 → $142 | Maintains | Overweight | Get Alert |
03/09/2022 | Buy Now | 21.26% | Piper Sandler | Charles Neivert | $126 → $118 | Maintains | Neutral | Get Alert |
01/31/2022 | Buy Now | 33.59% | Barclays | Duffy Fischer | $128 → $130 | Maintains | Equal-Weight | Get Alert |
01/11/2022 | Buy Now | 69.56% | Morgan Stanley | Vincent Andrews | $142 → $165 | Maintains | Overweight | Get Alert |
12/08/2021 | Buy Now | 41.81% | Wells Fargo | Michael Sison | — | Maintains | Overweight | Get Alert |
12/08/2021 | Buy Now | 54.15% | Keybanc | Aleksey Yefremov | — | Maintains | Overweight | Get Alert |
11/12/2021 | Buy Now | 29.48% | Piper Sandler | Charles Neivert | — | Initiates | → Neutral | Get Alert |
11/04/2021 | Buy Now | 16.12% | RBC Capital | Arun Viswanathan | — | Maintains | Sector Perform | Get Alert |
11/01/2021 | Buy Now | 13.04% | JP Morgan | Jeffrey Zekaukas | — | Downgrade | Overweight → Neutral | Get Alert |
10/11/2021 | Buy Now | 22.29% | Keybanc | — | — | Maintains | Overweight | Get Alert |
The latest price target for Eastman Chemical (NYSE:EMN) was reported by Citigroup on June 27, 2024. The analyst firm set a price target for $111.00 expecting EMN to rise to within 12 months (a possible 14.07% upside). 36 analyst firms have reported ratings in the last year.
The latest analyst rating for Eastman Chemical (NYSE:EMN) was provided by Citigroup, and Eastman Chemical maintained their buy rating.
The last upgrade for Eastman Chemical Co happened on May 23, 2024 when UBS raised their price target to $128. UBS previously had a neutral for Eastman Chemical Co.
The last downgrade for Eastman Chemical Co happened on August 1, 2023 when Piper Sandler changed their price target from N/A to $96 for Eastman Chemical Co.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eastman Chemical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eastman Chemical was filed on June 27, 2024 so you should expect the next rating to be made available sometime around June 27, 2025.
While ratings are subjective and will change, the latest Eastman Chemical (EMN) rating was a maintained with a price target of $114.00 to $111.00. The current price Eastman Chemical (EMN) is trading at is $97.31, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.